SWK Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SWKH research report →
Price Chart
About the company
SWK Holdings Corporation (SWKH) operates as a specialized financial institution, primarily concentrating its efforts within the healthcare sector. The company's operations are distinctly divided into two core segments: Finance Receivables and Pharmaceutical Development. Within its finance division, SWK offers bespoke funding solutions tailored to a diverse array of life science enterprises.
- CEO
- Jody. D Staggs
- IPO
- 1999
- Employees
- 24
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on SWKH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $192.33M
- P/E
- -27.41
- Fwd P/E
- 7.58
- PEG
- 0.23
- P/S
- 6.65
- P/B
- 0.82
- EV/EBITDA
- 10.04
- Div Yield
- 25.16%
- Gross Margin
- 95.99%
- Op Margin
- 55.00%
- Net Margin
- -24.45%
- ROE
- -2.88%
- ROIC
- -2.94%
Latest fiscal year · YoY change
- Revenue
- $40.76M-9.4%
- Gross Profit
- $38.84M-9.2%
- Op Income
- $24.02M
- Net Income
- $-2,533,000-118.8%
- EPS
- $-0.21-119.3%
- OCF Growth
- +18.4%
- FCF Growth
- +16.9%
- 52W High
- $17.90
- 52W Low
- $12.54
- 50D MA
- $16.96
- 200D MA
- $16.04
- Beta
- 0.30
- RSI (14)
- 33
- Avg Volume
- 9.40K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SWK Holdings said Q1 results were in line with expectations, highlighted a 12% annualized return on tangible finance book value, and emphasized a strong lending opportunity set despite balance-sheet and credit-resolution constraints.· October 10, 2025
- Financial segment non-GAAP net income was $7.3 million, equal to a 12% annualized return on tangible finance book value.
- GAAP pretax net income was $4.5 million, or $0.35 per diluted share; reported net income was $4.6 million.
- Gross total investment assets reached an all-time high of $250 million, and portfolio effective yield rose to 15.5% from 13.9% a year ago.
- SWK adopted CECL, building an $11.8 million allowance for credit losses and recording a $9.7 million reduction in book value.
- Management said the lending pipeline is attractive, but deployment is constrained by limited balance-sheet capacity and they are still working on additional financing capacity.
SWK reported Q1 2023 GAAP pretax net income of $4.5 million, or $0.35 per diluted share, and net income of $4.6 million. Financial segment non-GAAP net income totaled $7.3 million, representing a 12% annualized return on tangible finance book value. Gross total investment assets reached $250 million, up from $238 million at the end of 2022 and $196 million at March 31, 2022; portfolio effective yield was 15.5%, up from 13.9% in Q1 2022. The company adopted CECL, resulting in an $11.8 million allowance for credit losses and a $9.7 million reduction in book value. Looking ahead, management said Finance Receivables revenue over the next three quarters should be comparable to Q1 2023 absent any material unforeseen payoffs.
Jody Staggs framed the quarter as solid and in line with expectations, saying the financial segment’s return was a good baseline that could improve with disciplined underwriting and leverage. He stressed that the current lending environment is attractive, with new term sheets being issued at mid- to high-teens cost of capital, but he also acknowledged the company is fairly deployed and needs more capital to pursue more opportunities. His tone was confident but measured, especially on balance-sheet funding, where he said they are working through challenges and do not want to overpromise on timing.
Yvette Heinrichson focused on the reported numbers and the accounting impact of CECL. She said Q1 net income was $4.6 million after a $0.1 million income tax benefit, with revenue down year over year due to a $5.3 million decline from receivables paid off in 2022, partially offset by a $4.4 million increase from newer investments and added funding to existing borrowers. Operating expenses fell to $3.4 million from $5.1 million a year ago, including Enteris operating expenses of $1.4 million versus $2.6 million and Finance Receivables segment operating expenses of $2 million versus $2.2 million. She also explained the $11.8 million CECL allowance, the $0.4 million liability for unfunded commitments, and the $9.7 million accumulated-deficit reduction after deferred tax assets.
Analyst questions centered on the CECL reserve mechanics, capital deployment, funding capacity, how SWK is protecting itself in a tighter capital-raising environment, and the expected Enteris cost increase in Q2. Management said CECL is a general reserve across the portfolio rather than a specific-loan haircut, and emphasized it is an accounting change rather than a signal of expected losses. On capital, Jody said the company has good pipeline opportunities but is constrained by being fairly deployed; he expects more loans once additional ABL capacity or other capital is secured, though timing remains uncertain. On Enteris, he said the Q2 increase should only be in the hundreds of thousands of dollars due to severance, retention, strategic-review, and final R&D costs.
The call showed solid profitability in the financial segment, a record level of gross investment assets, and an effective yield near an all-time high. Management also said the lending environment is attractive, the pipeline is good, Enteris expense run-rate is lower, and there were $7 million of CDMO proposals bid year-to-date, suggesting potential second-half revenue growth.
SWK is still working through two nonaccrual-related situations, including Flowonix and Ideal, and management said some borrowers may need additional funding during 2023. The company also remains balance-sheet constrained, which limits new originations, and management was clear that additional capital or leverage is needed but the timing is still TBD. Enteris is facing one-time second-quarter costs, and the company is still evaluating strategic alternatives for that business.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.2%
- Shares Outstanding
- 12.10M
- Float Shares
- 11.40M
of shares held by institutions
59 13F filers
Buy/sell ratio 1.67. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 213.54K | ▲ 16.84K |
| Cwm, LLC | 1.91K | ▲ 4 |
Held by 1 ETFs
Biggest fund positions in SWKH by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 6, 26 | Carlson Capital, L.P. | other | 8,493,088 |
| Apr 6, 26 | Carlson Capital, L.P. | other | 8,632,093 |
| Jun 16, 25 | Hatcher Robert K. | other | 3,858 |
| Jun 16, 25 | Albright Jerry | other | 3,858 |
| Jun 16, 25 | Dotter Laurie L. | other | 3,858 |
| Apr 15, 25 | Staggs Joe David JR | other | 18,750 |
| Apr 15, 25 | Staggs Joe David JR | other | 15,000 |
| Apr 15, 25 | Staggs Joe David JR | other | 25,857 |
| Apr 15, 25 | Staggs Joe David JR | other | 18,750 |
| Apr 15, 25 | Staggs Joe David JR | other | 15,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SWKH coverage
Recent articles, reports, and earnings notes.
No research on SWKH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SWKH report →Here's Why Stanley Black & Decker (SWK) is a Strong Value Stock
zacks.com · Nov 17
Stanley Black & Decker, Inc. (SWK) Presents at Baird 2026 Global Industrial Conference 2026 Transcript
seekingalpha.com · Nov 12
SWK or LECO: Which Is the Better Value Stock Right Now?
zacks.com · Nov 11
Stanley Black & Decker (SWK) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com · Nov 5
Stanley Black & Decker, Inc. (SWK) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 4
SWK's Q3 Earnings Surge on Margin Expansion, 2026 Outlook Raised
zacks.com · Nov 4
Stanley Black & Decker (SWK) Reports Q3 Earnings: What Key Metrics Have to Say
zacks.com · Nov 4
Stanley Black & Decker (SWK) Surpasses Q3 Earnings and Revenue Estimates
zacks.com · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.